Q3 2025 EPS Estimates for Henry Schein, Inc. (NASDAQ:HSIC) Cut by Analyst

Henry Schein, Inc. (NASDAQ:HSIC) – Equities researchers at Zacks Research dropped their Q3 2025 earnings estimates for shares of Henry Schein in a note issued to investors on Monday, July 29th. Zacks Research analyst R. Department now expects that the company will post earnings per share of $1.43 for the quarter, down from their previous forecast of $1.44. The consensus estimate for Henry Schein’s current full-year earnings is $5.16 per share.

Henry Schein (NASDAQ:HSIC) last released its quarterly earnings data on Tuesday, May 7th. The company reported $1.10 earnings per share for the quarter, topping the consensus estimate of $1.01 by $0.09. Henry Schein had a net margin of 3.12% and a return on equity of 13.51%. The business had revenue of $3.17 billion for the quarter, compared to analyst estimates of $3.21 billion. During the same quarter last year, the firm earned $1.21 EPS. Henry Schein’s quarterly revenue was up 3.7% compared to the same quarter last year.

Several other analysts also recently commented on the stock. Piper Sandler restated an “overweight” rating and set a $86.00 target price on shares of Henry Schein in a report on Friday, June 21st. Robert W. Baird upgraded shares of Henry Schein from a “neutral” rating to an “outperform” rating and raised their target price for the stock from $81.00 to $92.00 in a report on Monday, July 22nd. Baird R W upgraded shares of Henry Schein from a “hold” rating to a “strong-buy” rating in a report on Monday, July 22nd. Evercore ISI dropped their target price on shares of Henry Schein from $75.00 to $72.00 and set an “in-line” rating on the stock in a report on Tuesday, July 9th. Finally, UBS Group dropped their target price on shares of Henry Schein from $82.00 to $80.00 and set a “neutral” rating on the stock in a report on Wednesday, May 8th. One analyst has rated the stock with a sell rating, six have assigned a hold rating, six have issued a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $81.67.

Henry Schein Stock Down 0.7 %

Henry Schein stock opened at $71.94 on Thursday. The company has a debt-to-equity ratio of 0.47, a current ratio of 1.75 and a quick ratio of 1.02. The firm has a market capitalization of $9.21 billion, a price-to-earnings ratio of 24.30, a PEG ratio of 1.79 and a beta of 0.87. The company’s 50 day simple moving average is $68.03 and its 200 day simple moving average is $71.81. Henry Schein has a fifty-two week low of $60.01 and a fifty-two week high of $82.63.

Hedge Funds Weigh In On Henry Schein

A number of institutional investors have recently added to or reduced their stakes in the company. Arizona State Retirement System increased its holdings in Henry Schein by 0.4% during the fourth quarter. Arizona State Retirement System now owns 35,890 shares of the company’s stock worth $2,717,000 after buying an additional 149 shares during the last quarter. Empirical Finance LLC increased its holdings in Henry Schein by 3.5% during the first quarter. Empirical Finance LLC now owns 4,764 shares of the company’s stock worth $360,000 after buying an additional 160 shares during the last quarter. Covestor Ltd increased its holdings in Henry Schein by 12.8% during the first quarter. Covestor Ltd now owns 1,511 shares of the company’s stock worth $114,000 after buying an additional 171 shares during the last quarter. Keene & Associates Inc. boosted its position in Henry Schein by 4.0% during the first quarter. Keene & Associates Inc. now owns 4,505 shares of the company’s stock worth $340,000 after purchasing an additional 175 shares during the period. Finally, Sequoia Financial Advisors LLC boosted its position in Henry Schein by 3.2% during the second quarter. Sequoia Financial Advisors LLC now owns 5,680 shares of the company’s stock worth $364,000 after purchasing an additional 176 shares during the period. 96.62% of the stock is currently owned by institutional investors and hedge funds.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.